Compare · APP vs HCAT
APP vs HCAT
Side-by-side comparison of Applovin Corporation (APP) and Health Catalyst Inc (HCAT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APP and HCAT operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- APP is the larger of the two at $187.19B, about 1312.5x HCAT ($142.6M).
- Over the past year, APP is up 45.3% and HCAT is down 53.7% - APP leads by 99.0 points.
- APP has been more active in the news (20 items in the past 4 weeks vs 11 for HCAT).
- Both have 25 recent analyst ratings on file.
- Company
- Applovin Corporation
- Health Catalyst Inc
- Price
- $557.10-0.35%
- $1.93+0.00%
- Market cap
- $187.19B
- $142.6M
- 1M return
- +18.78%
- +22.15%
- 1Y return
- +45.25%
- -53.72%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2019
- News (4w)
- 20
- 11
- Recent ratings
- 25
- 25
Applovin Corporation
AppLovin Corporation engages in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps worldwide. The company's software solutions include AppDiscovery, a solution to automate, optimize, and manage user acquisition investments for business clients; and MAX, an in-app bidding solution that optimizes purchases of app ad inventory. Its business clients include various advertisers, internet platforms, and others. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
Latest APP
- Director Webb Maynard G Jr was granted 525 shares and sold $1,790,365 worth of shares (3,076 units at $582.04) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 3,157 units (SEC Form 4)
- Director Vivas Eduardo was granted 525 shares, increasing direct ownership by 0.01% to 6,948,997 units (SEC Form 4)
- Director Morgenfeld Todd R was granted 525 shares, increasing direct ownership by 4% to 14,312 units (SEC Form 4)
- Director Messing Barbara was granted 525 shares, increasing direct ownership by 5% to 10,150 units (SEC Form 4)
- Director Georgiadis Mary Margaret Hastings was granted 525 shares, increasing direct ownership by 1% to 36,710 units (SEC Form 4)
- Director Chen Herald Y was granted 525 shares, increasing direct ownership by 0.25% to 207,454 units (SEC Form 4)
- Director Billings Craig Scott was granted 525 shares, increasing direct ownership by 14% to 4,232 units (SEC Form 4)
- Applovin Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 144 filed by Applovin Corporation
- Chief Financial Officer (CFO) Stumpf Matthew sold $5,431,200 worth of shares (9,052 units at $600.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 177,450 units (SEC Form 4)
Latest HCAT
- Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
- Health Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
- CEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation
- Chief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes
- Chief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)
- General Counsel Landry Benjamin covered exercise/tax liability with 13,779 shares, decreasing direct ownership by 4% to 364,539 units (SEC Form 4) (tax liability)
- Director Larson-Green Julie was granted 12,710 shares, increasing direct ownership by 16% to 94,644 units (SEC Form 4)
- SEC Form DEFA14A filed by Health Catalyst Inc
- SEC Form DEF 14A filed by Health Catalyst Inc